Effects of celecoxib on hepatic adiponectin receptors in rats with nonalcoholic steatohepatitis
ZHU Feng-shang,LIU Su,YANG Chang-qing,CHEN Xi-mei,ZHU Liang
DOI: https://doi.org/10.3877/cma.j.issn.2095-2015.2012.01.004
2012-01-01
Abstract:Objective To explore the effects of celecoxib on hepatic adiponectin receptors(Adipo-R1,Adipo-R2)in rats with nonalcoholic steatohepatitis(NASH).Methods Thirty Sprague-Dawley male rats were randomly divided into the normal group(n=10),the model group(n=10,fed with a high-fat diet for 12weeks)and the celecoxib group(n=10,fed the same diet as NASH group supplemented with the solution of celecoxib 80 mgo.kg-1.d-1gavage daily from the 12th week for 8 weeks).Serum and liver samples were collected until used at the 20th week.Each histological sample by HE and Masson staining was evaluated for steatosis,inflammation and fibrosis.Biochemical parameters of antioxidant enzyme activities and adiponectin,TNF-α,prostaglandin E2(PGE2)in serum and hepatic samples were estimated by automatic biochemical analyzer and enzyme linked immunosorbent assay(ELISA)kit,respectively.The mRNA and protein expressions of Adipo-R1,Adipo-R2 and COX-2 were disclosed by real-time PCR and Western blot analysis.Changes in serum and liver biochemical indicators were used one-way analysis of variance(ANOVA)(S-N-K method)and liver pathological changes were used the Wilcoxon's signed-rank test for the statistical analysis,respectively.Results Compared with the model group,histological samples in the celecoxib group showed a significant improvement in fat,inflammation and fibrosis(χ2=29.130,P<0.001.χ2= 23.330,P <0.001.χ2=14.678,P=0.002).The levels of serum and liver tissues in total anti-oxidation competence,superoxide dismutase,catalase,glutathione peroxidase and malondialdehyde in celecoxib group were significantly ameliorated compared with those in the model group [Serum: F=6.116,P=0.002(T-AOC).F=14.572,P=0.022(T-SOD).F=8.393,P=0.0003(CAT).F=9.272,P=0.0014(GSH-PX).F=18.380,P=0.002(MDA).liver tissues: F=12.416,P<0.0001(T-AOC).F=44.276,P=0.0002(T-SOD).F=28.269,P=0.0003(CAT).F=16.392 P=0.010(GSH-PX).F=5.367,P=0.0016(MDA)].Real-time PCR and Western blot revealed mRNA and protein expressions of Adipo R1,Adipo R2 were decreased(Adipo-R1mRNA,2.13 ±0.13vs.0.98±0.04,P=0.003.Adipo-R1 protein,0.72±0.07 vs.0.51±0.04,P=0.017.Adipo-R2 mRNA,1.75±0.19 vs.0.34±0.10,P=0.015.Adipo-R2 protein,0.49±0.03 vs.0.31±0.05,P=0.008)and COX-2 was increased(COX-2 mRNA,0.57±0.08 vs.2.83±0.24,P=0.005.Protein,0.45±0.04 vs.0.94±0.06,P=0.018)in the model group.After celecoxib intervention,all of those indicators exhibited markedly improved(Adipo-R1 mRNA,2.08± 0.22.Adipo-R2 mRNA,0.75 ±0.08.COX-2 mRNA,0.76 ±0.10.Adipo R1 protein,0.60 ±0.02.Adipo R2 protein,0.62 ±0.06.COX-2 protein,0.6 ±0.05,all P <0.01).Conclusions Celecoxib is effective in the treatment of experimental NASH,at least in part,through increasing the expressions of hepatic Adipo-R1 and Adipo-R2.